First Avenue Ventures
Overview
First Avenue Ventures is a venture capital firm, accelerator, and incubator based in Birmingham, Alabama, that invests in and supports early-stage companies.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Nyad | Mar 2026 | Pre Seed | Co-investor |
| Jana Care | Nov 2023 | Series B | Co-investor |
| CytoSite Bio | Aug 2018 | Series A | Co-investor |
| TriAltus Bioscience | Apr 2019 | Seed | Co-investor |
| Resbiotic Nutrition, Inc. | Oct 2021 | Seed | Co-investor |
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is First Avenue Ventures based?
First Avenue Ventures is headquartered in Birmingham, Alabama, United States.
When was First Avenue Ventures founded?
First Avenue Ventures was founded in 2014.
How many portfolio companies does First Avenue Ventures have?
First Avenue Ventures has 7 portfolio companies in Caplight's dataset.
What are some companies in First Avenue Ventures's portfolio?
Portfolio companies visible on Caplight include Nyad, Jana Care, CytoSite Bio, TriAltus Bioscience, Resbiotic Nutrition, Inc..
What was First Avenue Ventures's most recent investment shown here?
First Avenue Ventures's most recent investment in this portfolio sample was in Nyad in 2026.
What sectors does First Avenue Ventures focus on?
First Avenue Ventures focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, AI, Data & Cloud Infrastructure, Frontier & Industrial Tech, Consumer & Commerce, Frontier & Industrial Tech.
What company stages does First Avenue Ventures focus on?
Stage focus information for First Avenue Ventures is not publicly available.